Melanoma, recognized as the most aggressive form of skin cancer, poses significant risks when it metastasizes to the brain.
Melanoma News
Metastatic Melanoma Study Finds Immunotherapy Resistance Mutations in Immune-Linked Genes
NEW YORK – A research team led by investigators at the Dana-Farber Cancer Institute and the Broad Institute has uncovered somatic mutations linked to immunotherapy resistance in metastatic melanoma patients who experienced disease recurrence and acquired drug resistance after an initial response to immune checkpoint immunotherapy (ICI).
Dr Hamid on the Potential for Cancer Vaccines in Melanoma
Source: OncLive, February 2025 Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute, provides insight on the…
Read More Dr Orloff on Treatment Strategies for Rapidly Progressing Uveal Melanoma
Marlana M. Orloff, MD, associate professor, Jefferson University; physician, Department of Medical Oncology, Sidney Kimmel Cancer Center, discusses optimal treatment strategies for patients with aggressive uveal melanoma.